I. Introduction
The extent of axillary lymph node involvement is the most established and reliable prognostic factor for subsequent metastatic disease and survival 1 .
The technique of sentinel node biopsy was developed with the goal of reducing the morbidity associated with surgical staging of the axilla in patients with no palpable axillary nodes.
Morbidity rates are substantially lower with sentinel node biopsy than with axillary dissection. Doing SLNB is time consuming and may require IHC study, technical expertization and also requires a team of nuclear medicine specialist, Surgeon and pathologist. More over SLNB is not available at all centres and is also not cost effective.
Therefore if the node-positive patients can be identified pre-operatively, they can proceed directly to singlestage breast and axillary surgery without SNLB 2 . Among the imaging modalities, ultrasound has been the most frequently investigated because of its noninvasive nature and the ease of its use for evaluating the axilla. It is used to detect alterations in the size, shape and contours of lymph nodes, as well as detecting changes in the morphology and texture of the nodal cortex: it can thereby identify the presence of the underlying metastasis 3 .
. the sensitivity of which is further increased if combined with ultrasound guided fine needle aspiration cytology of any sonographically suspicious lymph nodes 4, 5, 6 . Ultrasound-guided fine-needle aspiration (FNA) is a quick nonmorbid method of staging disease in the axilla With the sonographic criteria used to identify abnormal nodes have been described, the ultrasonography of the axilla has the potential to emerge as a non invasive, non ionising modality to detect axillary metastases in breast carcinoma patients 7 . Only patients with negative findings at ultrasound-guided FNA will need to undergo sentinel lymphadenectomy for evaluation of the axilla
II.
Materials And Methods 
SUSPICIOUS -if L/D ratio <1.5 with absence of fatty hilum and hypoechoic cortex (fig 3).
Each of these 164 lymph nodes seen on USG underwent USG Guided FNA to confirm the USG findings.
2.6 USG Guided FNA procedure: Correlation between sonographic lymph node category and USG Guided FNAC: 
IV.
DISCUSSION Ultrasound of axilla permits the visualisation of lymph node size, shape, contour and changes in cortical morphology and texture that appear to be associated with the presence of axillary metastases. However, sonographic signs of metastatic disease sometimes overlap with those of benign reactive changes, limiting the ability of this modality alone to accurately stage the axilla. So, to increase the diagnostic accuracy of the USG, the tissue diagnosis of that particular lymph node evaluated by USG was essential and this was achieved by USG Guided FNA.
In our study, USG detected a total of 164 lymph nodes in 52 axillas with no lymph nodes seen in rest 5 axillas. Lymph nodes were evaluated for specific USG characteristics like L/D ratio, presence or absence of fatty hilum and for echogenecity and any morphological changes in cortex(notching, distortion).
Out of total 164 lymph nodes evaluated on ultrasonography, 63.4% had L/D Ratio <1.5, 65% had absent fatty hilum and 64.6% of them showed hypoechoic cortex.
Based on these specific characteristics of USG, lymph nodes were categorised as benign, indeterminate and suspicious.
Out of 164 lymph nodes, USG labelled 52 (31.7%) lymph nodes as benign, 15 (9%) as indeterminate and 97 (59%) lymph nodes as suspicious.
Out of 52 axillas, a total of 164 lymph nodes were evaluated on USG and all of them were subjected to undergo USG Guided FNA. Out of 164 lymph nodes, 115 (70%) were positive for malignancy, 40(24%) were negative for malignancy and 9 (5.4%) were insufficient for cytologic evaluation which were considered as negative for data analysis thus increasing negative for malignancy to 49(30%).
In our study, USG 0of axilla in correlation with USG Guided FNA showed the sensitivity, specificity, positive predictive value and negative predictive value of 92.2%, 87.8%, 94.6% and 82.7% respectively.
The overall sensitivity and specificity of USG alone was 67.9% and 91%, but by adding USG Guided FNA, the sensitivity increased to 92.2% and specificity to 87.8%.
USG alone showed the accuracy of 86.5% which was improved to 90.9% by adding USG Guided FNA. A Moore et al (2008) 11 reported in their study in 112 patients that the overall sensitivity and specificity values for sonography alone were 81% and 69% respectively. Adding fine needle aspiration improved the specificity of USG to 100%, leaving the sensitivity unchanged (82%).
On correlation of specific USG characteristics with USG Guided FNA, the sonographic feature most predictive of malignancy was absence of fatty hilum with accuracy of 91.5%. Hypoechoic cortex was the next best predictor with accuracy of 90.9%, followed by L/D ratio with 84.8% of accuracy.
Martha B M et al. (2010) 12 found in their study that the sonographic feature most predictive of a positive USG Guided FNA result was the absence of a fatty hilum.
Bedi et al. (2008) 13 suggested that hypoechoic cortex with focal cortical thickening is most predictive of malignancy.
On correlating tumor size with USG characteristics and USG Guided FNA, we found that USG Guided FNA positivity increased steadily with increase in tumor size. Tumors with T1 (1-2 cms) size showed USG Guided FNA positivity of 55%, 73% in T2 (2-5 cms) and 93% positivity in T3 (>5 cms) size tumors.
The ability of USG to detect more suspicious lymph nodes increased with increasing tumour size with 16% in T1 increased to 73% in T2 category.
Martha B M et al. (2010) 12 also found that the sensitivity of USG Guided FNA to detect metastatic disease in the axilla increased with increasing primary tumor size.
On correlating the histopathologic grade with USG Guided FNA, we found that tumour with grade II showed more USG Guided FNA positivity with 81% followed by grade III (51%) and grade I (41%).
The sensitivity, specificity, positive predictive value and negative predictive value of USG of axilla in correlation with histo-pathology was found to be 67.9%, 91%, 64.6% and 92.1% respectively in our study. The accuracy of USG to predict axillary metastasis was 86.5% in our study.
Vaidya et al (1996) reported results for USG with high specificity and PPV of 90% each but low sensitivity and NPV of 69% each.
Sung et al (2010) 8 in their study reported sensitivity of 55.6%, specificity of 77.5%, PPV of 60% and NPV of 74.2%. Kebudi (2005) 9 reported sensitivity, specificity, PPV and NPV for USG in predicting axillary metastases to be 79.1%, 77.7%, 82.6% and 73.6% respectively.
Jung hee shin et al. (2005) 10 reported the sensitivity, specificity and accuracy of ultrasonography to be 75%, 82.6% and 78.7%, respectively, in their study.
US has been proved to have a higher sensitivity (45-84%) and specificity (72-97%) for the detection of metastatic axillary lymph nodes in breast cancer than a clinical examination or the other imaging techniques in various studies. On correlating tumor size with USG characteristics and USG Guided FNA, we found that USG Guided FNA positivity increased steadily with increase in tumor size. Tumors with T1 (1-2 cms) size showed USG Guided FNA positivity of 55%, 73% in T2 (2-5 cms) and 93% positivity in T3 (>5 cms) size tumors. The ability of USG to detect more suspicious lymph nodes increased with increasing tumour size with 16% in T1 increased to 73% in T2 category.
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In conclusion, only those patients who showed benign or indeterminate features of lymph nodes on USG and had negative USG Guided FNA of suspicious lymph node will require SLNB as the staging procedure. Rest of the patients who showed definite features of lymph node involvement on USG and positive USG Guided FNA may undergo ALND directly as a part of primary breast surgery, thus saving time and also avoiding the morbidities associated with SLNB as mentioned earlier.
